A Top 10 pharmaceutical client required a mobile technology solution to collect safety and effectiveness data on a groundbreaking treatment for an ultra-rare disease in a global gene therapy prospective registry. With a single principal investigator to oversee enrolled patients in several countries on 2 continents, Clinical6 provided a multilingual technology platform to engage patients, parents, caregivers, and local healthcare providers.
Explore related content and topics
Newsletter
Industry Watch
This week’s issue of Industry Watch is focused on proposed changes to US lung cancer screening guidelines which will hopefully result in increased…
Read More
White Paper
Crossing the Finish Line
Trial participation exposes individuals to pressures that may become hurdles on the way to completing the study. This whitepaper from PRA’s Center…
View Resource
Blog
Finding a Cure for Spinal Muscular Atrophy
Read Story
View all related content and resources for Rare Disease
Explore Insights